Chinese conglomerate Fosun International has forecast a sharp rebound in first-half earnings, signalling that its multi-year strategy to streamline operations and focus on core businesses is beginning to deliver tangible financial results.
The Hong Kong-listed company (HKEX: 00656) expects profit attributable to shareholders for the six months ended June 2026 to reach between RMB1.5 billion and RMB1.8 billion, representing a 127% to 172% increase compared with the same period last year.
According to the company, the improved outlook reflects stronger operational performance across its core business segments, higher industrial operating profits and continued improvements in business quality.
The announcement marks one of Fosun’s strongest earnings recoveries in recent years as the group shifts its focus from aggressive expansion to profitability and operational efficiency.
Healthcare Business Continues to Lead Growth
One of the biggest contributors to the expected earnings improvement is Fosun Pharma, the group’s flagship healthcare subsidiary.
During the first quarter of 2026, Fosun Pharma reported revenue of RMB10.07 billion, up 6.93% year over year, while net profit attributable to shareholders increased 13.87% to RMB871 million.
Excluding non-recurring items, adjusted net profit rose 21.96%, suggesting that operational improvements rather than one-off gains are driving profitability.
Healthcare has become an increasingly important earnings pillar for Fosun as demand for pharmaceuticals, medical services and healthcare innovation continues to expand across China and international markets.
Insurance Operations Deliver Strong Momentum
Fosun’s wealth management division also posted encouraging results.
Fosun Insurance Portugal (Fidelidade) maintained double-digit premium growth across both its domestic Portuguese operations and international markets during the first half of the year.
Meanwhile, Pramerica Fosun Life Insurance generated RMB786 million in net profit during the first six months of 2026—already exceeding its total profit for the whole of 2025.
The performance highlights the growing importance of insurance within Fosun’s diversified portfolio, particularly as recurring premium income provides a more stable earnings base.
Consumer and Mining Businesses Add to Recovery
Growth was not limited to financial services and healthcare.
Consumer-focused subsidiary Yuyuan expects first-half net profit attributable to shareholders to reach between RMB120 million and RMB170 million, representing annual growth of 91.04% to 170.64%.
In the industrial segment, Hainan Mining forecasts net profit of RMB470 million to RMB550 million, an increase of 68% to 96% compared with the first half of 2025.
Notably, the mining business expects its first-half earnings alone to surpass its profit for the entire 2025 financial year, reflecting stronger commodity performance and improved operational execution.
Strategic Refocus Appears to Be Paying Off
Fosun has spent the past several years reshaping its business by reducing debt, divesting non-core assets and concentrating investment on sectors where it believes it holds long-term competitive advantages.
The strategy—described by the company as “streamlining operations and strengthening the business, focusing on core businesses”—has seen it scale back investments outside its priority industries while improving capital allocation across healthcare, insurance, consumer businesses and industrial operations.
This disciplined approach comes after heightened scrutiny of highly leveraged Chinese conglomerates, prompting many firms to prioritise balance-sheet strength and sustainable profitability over rapid expansion.
Why Investors Are Watching
The positive profit alert suggests Fosun’s restructuring programme is entering a new phase, with stronger earnings beginning to validate its strategic overhaul.
While the company has yet to release its full interim financial results, investors will be looking for evidence that margin improvements, cash generation and operational efficiency can be sustained through the remainder of 2026.
If the anticipated earnings materialise, Fosun could further strengthen investor confidence that its transition from asset-heavy expansion to focused, cash-generating growth is gaining momentum.
For a conglomerate that has spent recent years reshaping its portfolio, the latest guidance indicates that the emphasis on core businesses is translating into measurable financial performance rather than remaining a long-term strategic ambition.
Get in touch with our fintech expert
